Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients, with stroke history and renal dysfunction?: Response

dc.authoridErsoy, Yuksel/0000-0002-8035-4532
dc.authorwosidErsoy, Yuksel/S-7503-2016
dc.contributor.authorMacWalter, RS
dc.contributor.authorWong, KYK
dc.contributor.authorWong, SYS
dc.contributor.authorStruthers, AD
dc.contributor.authorErsoy, Y
dc.date.accessioned2024-08-04T20:57:33Z
dc.date.available2024-08-04T20:57:33Z
dc.date.issued2003
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage9en_US
dc.identifier.issn0039-2499
dc.identifier.issn1524-4628
dc.identifier.issue1en_US
dc.identifier.startpage9en_US
dc.identifier.urihttps://hdl.handle.net/11616/102699
dc.identifier.volume34en_US
dc.identifier.wosWOS:000180251100013en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofStrokeen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleConverting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients, with stroke history and renal dysfunction?: Responseen_US
dc.typeLetteren_US

Dosyalar